These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
3. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675 [TBL] [Abstract][Full Text] [Related]
4. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products. Dekant W; Melching-Kollmuss S; Kalberlah F Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711 [TBL] [Abstract][Full Text] [Related]
5. Integrated decision-tree testing strategies for developmental and reproductive toxicity with respect to the requirements of the EU REACH legislation. Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF Altern Lab Anim; 2008 Feb; 36(1):65-80. PubMed ID: 18333715 [TBL] [Abstract][Full Text] [Related]
6. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576 [TBL] [Abstract][Full Text] [Related]
7. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models. Pickford DB Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730 [TBL] [Abstract][Full Text] [Related]
8. Alternative test methods in inhalation toxicology: challenges and opportunities. Costa DL Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462 [TBL] [Abstract][Full Text] [Related]
10. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment. Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877 [TBL] [Abstract][Full Text] [Related]
11. Current and future needs for developmental toxicity testing. Makris SL; Kim JH; Ellis A; Faber W; Harrouk W; Lewis JM; Paule MG; Seed J; Tassinari M; Tyl R Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):384-94. PubMed ID: 21922641 [TBL] [Abstract][Full Text] [Related]
12. Protein biomarkers for in vitro testing of toxicology. Schrattenholz A; Šoškić V; Schöpf R; Poznanović S; Klemm-Manns M; Groebe K Mutat Res; 2012 Aug; 746(2):113-23. PubMed ID: 22405942 [TBL] [Abstract][Full Text] [Related]
13. Assuring safety without animal testing: the case for the human testis in vitro. Chapin RE; Boekelheide K; Cortvrindt R; van Duursen MB; Gant T; Jegou B; Marczylo E; van Pelt AM; Post JN; Roelofs MJ; Schlatt S; Teerds KJ; Toppari J; Piersma AH Reprod Toxicol; 2013 Aug; 39():63-8. PubMed ID: 23612449 [TBL] [Abstract][Full Text] [Related]
14. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report. van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444 [TBL] [Abstract][Full Text] [Related]
15. A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment. Vogel R; Seidle T; Spielmann H Reprod Toxicol; 2010 Apr; 29(2):242-5. PubMed ID: 19808091 [TBL] [Abstract][Full Text] [Related]
16. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation. De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383 [TBL] [Abstract][Full Text] [Related]
17. Integrating (Q)SAR models, expert systems and read-across approaches for the prediction of developmental toxicity. Hewitt M; Ellison CM; Enoch SJ; Madden JC; Cronin MT Reprod Toxicol; 2010 Aug; 30(1):147-60. PubMed ID: 20006701 [TBL] [Abstract][Full Text] [Related]
18. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E; Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066 [TBL] [Abstract][Full Text] [Related]
19. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it. Llorens J; Li AA; Ceccatelli S; Suñol C Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764 [TBL] [Abstract][Full Text] [Related]
20. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy. Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]